uconn health
Chemical Safety
Chemical Safety Guidance
- Chemical Hygiene Plan (CHP)
- Chemical Inventory Policy
- Chemical Waste Disposal Guidance
- Chemical Waste Minimization and Waste Trends
- Guidelines for Laboratory Use of Chemical Carcinogens
- Hydrofluoric Acid Exposure Emergency Response
- Lab Specific Operating Procedures (LSOP’s
- 2-Chloroethanol
- Acetyl Chloride
- Ammonium Nitrate
- Bouins Solution
- Dimethyl Sulfate
- Hydrazine
- Hydrofluoric Acid
- Perchloric Acid
- Peroxide Forming Chemicals
- Picric 2 Percent
- Piranha Solution
- Propylene oxide
- Pyrophorics
- Sodium Azide
- Qiagen Chemicals and Waste Identification
- Universal Waste Procedures
Chemical Safety Forms
- Chem Cards
- Chemical Compatibility Chart
- Chemical Hazard Posting
- Chemical Re-Distribution Log
- Chemical Waste Pick Up Form
- Emergency Door Posting
- Eyewash Inspection Log
- GHS (Globally Harmonized System) Pictograms and Hazards Poster
- Laboratory Disposal Instructions – Quick Sheet
- Laboratory Inspection/Audit Form – Example
- Personal Protective Equipment
- Punch List for Laboratory Chemical Safety
- Reactivity Evaluation Form
- Specific Disposal Instructions – Quick Sheet
- Unknown Chemical Waste
Other Resources
-
- Ansell-Permeation and Degradation Database
- Chemical Resistant Glove Guide
- Connecticut Poison Control Center (1-800-222-1222)
- Consolidated Sterilizer Systems – Autoclave Instructional Videos
- NOAA-Chemical Reactivity Worksheet
- OSHA PPE
- PubChem Chemistry Database
- Safety Data Sheet (SDS) Sources
- UConn Campus Health and Safety
- UConn Health Emergency Department (911)
- UConn Health Occupational and Environmental Medicine Employee Health Services
Educational Material – Online Resources
- American Medical Association
- Association for the Accreditation of Human Research Protection Programs
- Center for Drug Evaluation & Research/IND Information
- Clinical Decision Support Software
- Council for International Organizations of Medical Sciences
- Declaration of Helsinki
- Department of Health and Human Services
- Department of Health and Human Services/HIPAA
- Device Regulations
- Device Software Functions Including Mobile Medical Applications
- Digital Health Policy Navigator
- Ethics – Belmont Report
- Ethics (Code of) for Sociologists
- Ethics (Code of) for Psychologists and Code of Conduct
- Ethics – The Hastings Center
- Ethics – Kennedy Institute of Ethics Journal
- Federal Regulations/retrieval of
- Federal Regulations – The Common Rule and Subparts B, C and D
- Food and Drug Administration (FDA)
- FDA regulations for Protection of Human Subjects
- FDA regulations for Institutional Review Boards
- FDA regulations for Investigational New Drugs
- FDA regulations for Investigational Devices
- FDA regulations for Humanitarian Use Devices
- Genome-wide Association Studies
- Good Clinical Practice/Consolidated Guidance
- Good Clinical Practice in FDA-Regulated Clinical Trials
- Hastings Center
- Health Insurance Portability and Accountability Act (HIPAA) Privacy Regulations
- International Compilation of Human Research Protections
- National Institutes of Health
- National Institutes of Health – Clinical e-Protocol Writing Tool
- Office of Extramural Research/Certificates of Confidentiality
- Office for Human Research Protections
- Office of Research Integrity
- Policy for Device Software Functions and Mobile Medical Applications
- Public Act No. 05-149 Permitting Stem Cell Research
- Public Responsibility in Medicine and Research
- Research Advocacy Network
- Software as a Medical Device (SaMD)
- Translation Services – Global Language Solutions
- Translation Services – Lighthouse Translations and Interpretations
- Translation Services – The Language Link of CT
- Translation Services – UMass Translation Center
- World Health Organization
- World Medical Association
- How to Determine if Your Product is a Medical Device
- Regulatory Guidance for Academic Research of Drug and Devices
- Is my Device Study Exempt from Investigational Device Exemption (IDE) Regulations?
Translation of Documents and the Consent Process
Study related documents (e.g., the informed consent document, the HIPAA authorization, a survey) must be presented in a language understandable to the subject. Two methods of translation are acceptable to the HSPP/IRB. The preferred method is that the document be translated by a professional translation service that will attest to the accuracy of the translation. The second is the use of back-translation into English. In this scenario
- the English version of the document is translated into the foreign language,
- the name and credentials of the individual who did the translation are provided to the IRB by the investigator,
- another individual who has not seen the English version of the document translates the foreign language document back into English,
- this individual provides his/her name, credentials and a statement that s/he has not seen the original English version to the IRB via the investigator,
- both English versions of the form and the foreign language version are submitted to the IRB for review, and
- the IRB will compare both English versions of the documents.
If the IRB determines the translation is accurate the foreign language document will be approved for use.
The informed consent process must also be conducted in a language understandable to the subject and may therefore require the use of a translator. The translator may be a family member or friend of the subject, an employee of the institution or may be hired by the principal investigator.
Obtain Approval of English Versions First
Although you are not required to do so, you may want to obtain approval of the English version of your documents before you go through the process of having them translated. In this manner, if the IRB requires changes to the English version in order to secure approval, you will not have to go through the translation process again. If you plan to obtain approval for the English version documents first you should indicate this on the IRB Application Checklist that translated documents will be submitted for approval via a request for addendum/modification before they are used with subjects.
The PI is responsible for covering the cost of the translation. The cost of the translation will not be incurred by the subjects.
Professional Translation Services
Quality Assurance, Quality Improvement and Research
Federal regulations define research as the systematic investigation, including development, testing and/or evaluation, designed to develop or contribute to generalizable knowledge. Federal regulations define a human subject as a living individual about whom an investigator (whether professional or student) conducting research obtains (1) data through intervention or interaction with the individual or (2) identifiable private information. Investigators must seek IRB review and approval for research projects involving human subjects before the project commences.
However, investigators are not required to obtain IRB approval for other activities (e.g. clinical care, quality improvement, quality assurance, public health activities); unless the proposed activity also meet the definition of human subject research. This tool may be useful in guiding individuals as to whether a project is quality improvement or research, or both. If an investigator has any questions as to whether an activity also constitutes human subject research, it is strongly recommended that a Human Subject Research Determination Form be submitted to the IRB to obtain an official ruling as to whether IRB approval is required before the activity commences.
The Office for Human Research Protections (OHRP) has posted several Frequently Asked Questions regarding Quality Improvement activities.
Public Health Research: Surveillance, emergency responses, and program evaluations do not meet the definition of human subjects research. These activities constitute public health activities with the primary intent to prevent disease in a particular population, improve a public health program, or to provide emergency disaster relief. Therefore, these activities do not have to be reviewed by an IRB.
Institutional Policies Related to Human Subjects Protections
Investigators and study personnel should be familiar with the following policies that relate to human subject protections. (Policies are in PDF.)
- Authority of the Human Subjects Protection Office, Policy 2004-02
- Clinical Research / Trials Budget Review, Policy 2006-07
- Clinical Research Trials Facility Discount for Hospital-Based Outpatient Programs, Policy 2010-01
- Clinical Research Trials Patient Billing Compliance, Policy 2006-08
- Clinical Trials Under Contract – Administrative Requirements, Policy 2007-06
- Confidentiality, Policy 2002-43
- Conflicts of Interest in Research Policy, 2006-01
- Data Ownership Policy, 2003-42
- Electronic Communication of Confidential Data, Policy 2011-004
- Information Security: Anti-Virus and Software Update, Policy 2005-10
- Information Security: Data Authentication, Physical Safeguards, Policy 2011-01
- Information Security: Risk Assessment, Policy 2005-08
- Information Technology Security: Systems Access Control, Policy 2011-03
- IRB Approval of Human Research Conducted by Subcontractors, Policy 2004-04
- Manufacturing of Drugs, Devices or Biologics for Human Research, Policy 2005-12
- Mobile Computing Device (MCD) Security, Policy 2008-03
- Review and Approval of Research Involving Human Subjects, Policy 2002-42
- Review of Alleged Misconduct of Research
- Rules of Conduct, Policy 2002-03
- Written Agreements for Sponsored/Funded Research Involving Human Subjects, Policy 2004-05
Institutional Review Board – Short Form Consents
iRIS Training
iRIS Training Sessions:
Departments/Centers are encouraged to select one or two individuals who will be the point persons for navigating the iRIS system. The Educational and Development Specialist (EDS) will provide training for using the system to these individuals; and they in turn can train others in their department/center.
Individuals are invited and encouraged to request iRIS training. To schedule a session e-mail the HSPP at irb@uchc.edu. Classes are held in the L- Building – 5th Floor – Room L5035.
Terms & Definitions Used by OCTR
Budget Workbook
Electronic tool used by OCTR in conjunction with study team to identify, segregate and monitor charges
Clinical Research
- Patient-oriented research. Research conducted with human subjects (or on material of human origin such as tissues, specimens and cognitive phenomena) for which an investigator (or colleague) directly interacts with human subjects. This area of research includes:
- Mechanisms of human disease
- Therapeutic interventions
- Clinical trials
- Development of new technologies
- Epidemiologic and behavioral studies.
- Outcomes research and health services research.
Clinical Trial
A clinical trial is a systematic, organized, prospective intervention study in human subjects that is conducted according to a formal study plan (protocol) and that has measurable efficacy and/or safety-related outcomes that are amenable to statistical analysis. It employs one or more intervention technique(s) including prophylactic, screening, diagnostic, or therapeutic agents, devices, or procedures. It must have the approval of the IRB or the IRB’s review with a determination of exemption. Clinical trials are distinguished from other types of clinical research (e.g., behavioral research) that may need IRB approval but do not meet the other criteria of clinical trials.
Clinical Trials Initiation Form
Upon IRB approval, this form is generated by OCTR to notify all departments involved of the services to be charged to the trial. This form includes critical billing information such as: BANNER account number, party responsible for EPIC Research Billing Review, name of recipient of Transfer Vouchers, list of services to be charged, and category of sponsor.
Preliminary Budget Information Packet
OCTR document that initiates the Budget Workbook process. Packet is emailed to PI/Study Coordinator in response to query regarding doing a Budget Workbook; it is completed by the study team and returned to OCTR via email prior to study team meeting with OCTR staff
Protocol Induced Costs (PIC)
Items and services that are specifically excluded from the definition of Routine Clinical Services in a qualifying clinical trial such as:
- The investigational item or service itself
- Items and services provided solely to satisfy data collection and analysis needs and that are not used in the direct clinical management of the patient
- Items and services customarily provided by the research free of charge for any enrollee in the trial
- Items and services provided solely to determine trial eligibility
Qualifying Clinical Trial
As per the Medicare National Coverage Determination (“Routine Costs in Clinical Trials, also known as the CMS Clinical Trial Policy or “CMS CTP”): Any clinical trial receiving Medicare coverage of routine costs must meet both the basic three requirements and seven desirable characteristics to qualify for coverage.
https://www.cms.gov/Regulations-and-Guidance/Guidance/Transmittals/downloads/R74NCD.pdf
“Deemed” studies automatically meet the criteria for the seven desirable characteristics.
Routine Clinical Services (RC)
Routine costs of a clinical trial include all items and services that otherwise would be generally available to Medicare beneficiaries regardless of whether they are assigned to the experimental or control arm of a qualifying clinical trial. “Generally available” means that the item or service falls within an existing Medicare benefit category that is not excluded from coverage by another provision in the law and that is not the subject of an NCD stating that the item or service is not covered. If an item is covered outside of a clinical trial it is covered within the clinical trial.
Study
In this context, synomous with clinical trial/clinical research
Animal Research
Animals have been central to the advancement of knowledge that has led to a vast array of benefits to both human and animal health. The University of Connecticut regards the use of animals in research, teaching, and testing to be an integral component of continued progress in science, education, and agriculture. The University expects all of its animal facilities and programs to maintain high ethical standards for animal care and use, and to be operated in accordance with applicable federal, state, and local laws, regulations, policies, and guidelines.
The animal care and use program refers to all the components that exist in support of the University’s activities involving live animals. These components include facilities, employees, researchers, policies and procedures, equipment and animals. The Animal Care and Use Program is accredited by AAALAC International.
The Center for Comparative Medicine is responsible for providing veterinary care, veterinary husbandry services and expert consultation on the selection, care and use of animals in research and educational programs.
The Institutional Animal Care and Use Committee (IACUC) qualified through the experience and expertise of its members to oversee the University’s animal program, facilities, and procedures in accordance with the applicable laws, guidelines, and regulations.